Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022
Angela Rose, Patricia Bruijning‐Verhagen(Utrecht University), Isabela Ioana Loghin(Clinical Emergency Hospital Bucharest), Roberta Vaikutytė(Lithuanian University of Health Sciences), Irina Kislaya(German Center for Infection Research), George Panagiotakopoulos(National Public Health Organization), Jesús Castilla(Instituto de Salud Pública de Navarra), Diana Nonković(Croatian Hydrographic Institute), Petr Husa(Masaryk University), M. Simon(Centre National de la Recherche Scientifique), Zvjezdana Lovrić Makarić, Cyril Barbezange(Sciensano (Belgium)), Goranka Petrović(Hrvatski zavod za javno zdravstvo), Cristina Burgui(Instituto de Salud Carlos III), Virginia Martin(Instituto de Salud Carlos III), Corneliu Petru Popescu(Carol Davila University of Medicine and Pharmacy), Annamária Ferenczi(Semmelweis University), John Paul Cauchi(Queen Mary University of London), Lenka Součková(University Hospital Brno), Sarah Denayer(Sciensano (Belgium)), Els Van Nedervelde(Vrije Universiteit Brussel), Concepción Delgado‐Sanz(Instituto de Salud Carlos III), Aušra Džiugytė, Francisco Pozo(Instituto de Salud Carlos III), Indrė Jonikaitė(Lithuanian University of Health Sciences), Nathalie Bossuyt(Sciensano (Belgium)), J Horváth(Semmelweis University), F Annabel Niessen(National Institute for Public Health and the Environment), Ausenda Machado(National Institute of Health Dr. Ricardo Jorge), Nathalie Nicolay(European Centre for Disease Prevention and Control), Odile Launay(Délégation Paris 5), Jennifer Howard, Joaquín Baruch, Joan O’Donnell(Health Service Executive), Giedrė Gefenaitė(Lithuanian University of Health Sciences), Raquel Guiomar, Lucie Seyler(Universitair Ziekenhuis Brussel), Clara Mazagatos(Instituto de Salud Carlos III), Janine Reiche(Robert Koch Institute), Mirjam J. Knol(National Institute for Public Health and the Environment), Stella Michelaki(National Public Health Organization), Iván Martínez‐Baz(Instituto de Salud Carlos III), Christine Durier(Inserm), Róisín Duffy(Health Protection Surveillance Centre), Virtudes Gallardo(Junta de Andalucía), Nasséra Aouali(Roswell Park Comprehensive Cancer Center), Kristin Tolksdorf(Robert Koch Institute), L B Luong Nguyen(Hôpital Cochin), Lisa Domegan(Health Service Executive)
Cited by 18
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484
Tuberculosis in HIV-infected patients: a comprehensive review
|Clinical Microbiology and Infection|2004|333